Increased mucosal CD4+ T cell activation in rhesus macaques following vaccination with an adenoviral vector

Journal of Virology

Volumn 88, Issue 15, 2014, Pages 8468-8478

  Bukh, Irene ^a   Calcedo, Roberto ^a   Roy, Soumitra ^a,b   Carnathan, Diane G ^a   Grant, Rebecca ^a   Qin, Qiuyue ^a   Boyd, Surina ^a   Ratcliffe, Sarah J ^a   Veeder, Christin L ^a   Bellamy, Scarlett L ^a   Betts, Michael R ^a   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD28 ANTIGEN; CD69 ANTIGEN; FAS ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; KI 67 ANTIGEN; SIMIAN ADENOVIRUS 7 VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS PRESENTATION; CROSS REACTION; CYTOKINE PRODUCTION; FEMALE; INFECTION SENSITIVITY; LAMINA PROPRIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SIMIAN ADENOVIRUS 7; SIMIAN VIRUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ADENOVIRUSES, SIMIAN; ANIMALS; BLOOD; CD4-POSITIVE T-LYMPHOCYTES; GENETIC VECTORS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; MACACA MULATTA; RECTUM; VACCINATION;

EID: 84903884379     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03850-13     Document Type: Article

References (34)

1. Emini EA, Weiner DB. 2004. AIDS vaccines. Expert Rev. Vaccines 3:S1-S2. http://dx.doi.org/10.1586/14760584.3.4.S1.
2. McMichael AJ. 2006. HIV vaccines. Annu. Rev. Immunol. 24:227-255. http://dx.doi.org/10.1146/annurev.immunol.24.021605.090605.
3. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, Del Rio C, McElrath MJ, Casimiro DR, Gottesdiener KM, Chodakewitz JA, Corey L, Robertson MN. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881-1893. http://dx.doi.org/10.1016/S0140-6736(08) 61591-3.
4. Gray G, Hammer S. 2013. National Institute of Allergy and Infectious Diseases mini-summit on adenovirus platforms for HIV vaccines. National Institute of Allergy and Infectious Diseases, Bethesda, MD.
5. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step study: a case-cohort analysis. Lancet 372:1894-1905. http://dx.doi.org/10.1016/S0140-6736(08)61592-5.
6. + T cells. Nat. Med. 15:876-878. http://dx.doi.org/10.1038/nm.1989.
7. Benlahrech A, Harris J, Meiser A, Papagatsias T, Hornig J, Hayes P, Lieber A, Athanasopoulos T, Bachy V, Csomor E, Daniels R, Fisher K, Gotch F, Seymour L, Logan K, Barbagallo R, Klavinskis L, Dickson G, Patterson S. 2009. Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proc. Natl. Acad. Sci. U.S.A. 106:19940-19945. http://dx.doi.org/10.1073/pnas.0907898106.
8. Garnett CT, Erdman D, Xu W, Gooding LR. 2002. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J. Virol. 76:10608-10616. http://dx.doi.org/10.1128/JVI.76.21.10608-10616.2002.
9. Handley SA, Thackray LB, Zhao G, Presti R, Miller AD, Droit L, Abbink P, Maxfield LF, Kambal A, Duan E, Stanley K, Kramer J, Macri SC, Permar SR, Schmitz JE, Mansfield K, Brenchley JM, Veazey RS, Stappenbeck TS, Wang D, Barouch DH, Virgin HW. 2012. Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell 151:253-266. http://dx.doi.org/10.1016/j.cell.2012.09.024.
10. O'Brien KL, Liu J, King SL, Sun YH, Schmitz JE, Lifton MA, Hutnick NA, Betts MR, Dubey SA, Goudsmit J, Shiver JW, Robertson MN, Casimiro DR, Barouch DH. 2009. Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. Nat. Med. 15:873-875. http://dx.doi.org/10.1038/nm.1991.
11. Chakupurakal G, Onion D, Cobbold M, Mautner V, Moss PA. 2010. Adenovirus vector-specific T cells demonstrate a unique memory phenotype with high proliferative potential and coexpression of CCR5 and integrin alpha4beta7. AIDS 24:205-210. http://dx.doi.org/10.1097/QAD.0b013e328333addf.
12. Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415:331-335. http://dx.doi.org/10.1038/415331a.
13. Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, Tang A, Wilson KA, Chen M, Perry HC, Heidecker GJ, Freed DC, Carella A, Punt KS, Sykes KJ, Huang L, Ausensi VI, Bachinsky M, Sadasivan-Nair U, Watkins DI, Emini EA, Shiver JW. 2005. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. 79: 15547-15555. http://dx.doi.org/10.1128/JVI.79.24.15547-15555.2005.
14. Wilson NA, Reed J, Napoe GS, Piaskowski S, Szymanski A, Furlott J, Gonzalez EJ, Yant LJ, Maness NJ, May GE, Soma T, Reynolds MR, Rakasz E, Rudersdorf R, McDermott AB, O'Connor DH, Friedrich TC, Allison DB, Patki A, Picker LJ, Burton DR, Lin J, Huang L, Patel D, Heindecker G, Fan J, Citron M, Horton M, Wang F, Liang X, Shiver JW, Casimiro DR, Watkins DI. 2006. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J. Virol. 80:5875-5885. http://dx.doi.org/10.1128/JVI.00171-06.
15. Roy S, Sandhu A, Medina A, Clawson DS, Wilson JM. 2012. Adenoviruses in fecal samples from asymptomatic rhesus macaques, United States. Emerg. Infect. Dis. 18:1081-1088. http://dx.doi.org/10.3201/eid1807.111665.
16. Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW. 2005. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys. J. Virol. 79:12321-12331. http://dx.doi.org/10.1128/JVI.79.19.12321-12331.2005.
17. Roy S, Clawson DS, Adam VS, Medina A, Wilson JM. 2011. Construction of gene transfer vectors based on simian adenovirus 7. J. Gen. Virol. 92:1749-1753. http://dx.doi.org/10.1099/vir.0.032300-0.
18. Calcedo R, Vandenberghe LH, Roy S, Somanathan S, Wang L, Wilson JM. 2009. Host immune responses to chronic adenovirus infections in human and nonhuman primates. J. Virol. 83:2623-2631. http://dx.doi.org/10.1128/JVI.02160-08.
19. Zeger SL, Liang KY. 1986. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130. http://dx.doi.org/10.2307/2531248.
20. Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ. 2012. Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine. J. Clin. Invest. 122:359-367. http://dx.doi.org/10.1172/JCI60202.
21. Roy S, Vandenberghe LH, Kryazhimskiy S, Grant R, Calcedo R, Yuan X, Keough M, Sandhu A, Wang Q, Medina-Jaszek CA, Plotkin JB, Wilson JM. 2009. Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog. 5:e1000503. http://dx.doi.org/10.1371/journal.ppat.1000503.
22. Roy S, Calcedo R, Medina-Jaszek A, Keough M, Peng H, Wilson JM. 2011. Adenoviruses in lymphocytes of the human gastro-intestinal tract. PLoS One 6:e24859. http://dx.doi.org/10.1371/journal.pone.0024859.
23. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, Ghrayeb J, Forman MA, Montefiori DC, Rieber EP, Letvin NL, Reimann KA. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-860. http://dx.doi.org/10.1126/science.283.5403.857.
24. Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, Drummond DD, Legasse AW, Axthelm MK, Oswald K, Trubey CM, Piatak M, Jr, Lifson JD, Nelson JA, Jarvis MA, Picker LJ. 2009. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 15: 293-299. http://dx.doi.org/10.1038/nm.1935.
25. Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM, Brown SJ, Kulkarni P, Dubey SA, Kierstead LS, Casimiro DR, Mogg R, DiNubile MJ, Shiver JW, Leavitt RY, Robertson MN, Mehrotra DV, Quirk E. 2008. Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. Clin. Infect. Dis. 46:1769-1781. http://dx.doi.org/10.1086/587993.
26. Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JG, King CR, Andrews CA, Sheets R, Gomez PL, Mascola JR, Nabel GJ, Graham BS. 2006. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector. J. Infect. Dis. 194:1638-1649. http://dx.doi.org/10.1086/509258.
27. Pine SO, Kublin JG, Hammer SM, Borgerding J, Huang Y, Casimiro DR, McElrath MJ. 2011. Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans. PLoS One 6:e18526. http://dx.doi.org/10.1371/journal.pone.0018526.
28. Masopust D, Vezys V, Wherry EJ, Barber DL, Ahmed R. 2006. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J. Immunol. 176:2079-2083. http://dx.doi.org/10.4049/jimmunol.176.4.2079.
29. Kaufman DR, Liu J, Carville A, Mansfield KG, Havenga MJ, Goudsmit J, Barouch DH. 2008. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 181: 4188-4198. http://dx.doi.org/10.4049/jimmunol.181.6.4188.
30. Maluquer de Motes C, Hundesa A, Almeida FC, Bofill-Mas S, Girones R. 2011. Isolation of a novel monkey adenovirus reveals a new phylogenetic clade in the evolutionary history of simian adenoviruses. Virol. J. 8:125. http://dx.doi.org/10.1186/1743-422X-8-125.
31. Seto D, Chodosh J, Brister JR, Jones MS. 2011. Using the whole-genome sequence to characterize and name human adenoviruses. J. Virol. 85: 5701-5702. http://dx.doi.org/10.1128/JVI.00354-11.
32. Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC. 2007. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 110:1916-1923. http://dx.doi.org/10.1182/blood-2007-02-062117.
33. + T cells in multiple tissues during acute SIV infection. Nature 434:1093-1097. http://dx.doi.org/10.1038/nature03501.
34. Hutnick NA, Carnathan DG, Dubey SA, Cox KS, Kierstead L, Makadonas G, Ratcliffe SJ, Lasaro MO, Robertson MN, Casimiro DR, Ertl HC, Betts MR. 2010. Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality. PLoS One 5:e14385. http://dx.doi.org/10.1371/journal.pone.0014385.